These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 14632309
1. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Schaefer C. Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309 [Abstract] [Full Text] [Related]
2. [Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists]. Sørensen AM, Christensen S, Jonassen TE, Andersen D, Petersen JS. Ugeskr Laeger; 1998 Mar 02; 160(10):1460-4. PubMed ID: 9520613 [Abstract] [Full Text] [Related]
3. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors. Cooper WO. J Cardiovasc Nurs; 2008 Mar 02; 23(1):20-4. PubMed ID: 18158502 [Abstract] [Full Text] [Related]
4. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Quan A. Early Hum Dev; 2006 Jan 02; 82(1):23-8. PubMed ID: 16427219 [Abstract] [Full Text] [Related]
9. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Tabacova S, Little R, Tsong Y, Vega A, Kimmel CA. Pharmacoepidemiol Drug Saf; 2003 Dec 02; 12(8):633-46. PubMed ID: 14762979 [Abstract] [Full Text] [Related]
12. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations]. de Leeuw PW. Ned Tijdschr Geneeskd; 2006 Jul 22; 150(29):1605-7. PubMed ID: 16901062 [Abstract] [Full Text] [Related]
13. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Schaefer C, Meister R, Weber-Schoendorfer C. Arch Gynecol Obstet; 2010 Feb 22; 281(2):221-7. PubMed ID: 19444462 [Abstract] [Full Text] [Related]
15. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Garbis H, Elefant E, Diav-Citrin O, Mastroiacovo P, Schaefer C, Vial T, Clementi M, Valti E, McElhatton P, Smorlesi C, Rodriguez EP, Robert-Gnansia E, Merlob P, Peiker G, Pexieder T, Schueler L, Ritvanen A, Mathieu-Nolf M. Reprod Toxicol; 2005 Feb 22; 19(4):453-8. PubMed ID: 15749258 [Abstract] [Full Text] [Related]
18. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Diav-Citrin O, Shechtman S, Halberstadt Y, Finkel-Pekarsky V, Wajnberg R, Arnon J, Di Gianantonio E, Clementi M, Ornoy A. Reprod Toxicol; 2011 May 22; 31(4):540-5. PubMed ID: 21338666 [Abstract] [Full Text] [Related]